Midostaurin in patients with indolent systemic mastocytosis: An open-label phase 2 trial - 06/09/18
Doi : 10.1016/j.jaci.2018.06.003
Bjorn van Anrooij, MD a, b 
, Joanne N.G. Oude Elberink, MD, PhD a, Lambert F.R. Span, MD, PhD b, Jan G.R. de Monchy, MD, PhD a, Stefano Rosati, MD c, André B. Mulder, MD, PhD d, Johanna C. Kluin-Nelemans, MD, PhD b
, Joanne N.G. Oude Elberink, MD, PhD a, Lambert F.R. Span, MD, PhD b, Jan G.R. de Monchy, MD, PhD a, Stefano Rosati, MD c, André B. Mulder, MD, PhD d, Johanna C. Kluin-Nelemans, MD, PhD b a Department of Allergology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
b Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
c Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
d Department of Laboratory Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
| Supported by a research grant and free use of drug from Novartis. |
|
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
© 2018
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 142 - N° 3
P. 1006 - septembre 2018 Retour au numéro
Article précédent
- Insulin decreases expression of the proinflammatory receptor proteinase-activated receptor-2 on human airway epithelial cells
- Vivek D. Gandhi, Nami Shrestha Palikhe, Shereen M. Hamza, Jason R.B. Dyck, Jean Buteau, Harissios Vliagoftis
- Mast cell activation syndrome: Importance of consensus criteria and call for research
- Peter Valent, Cem Akin, Patrizia Bonadonna, Karin Hartmann, Sigurd Broesby-Olsen, Knut Brockow, Joseph H. Butterfield, Andreas Reiter, Jason Gotlib, Mariana Castells, Joshua D. Milner, Melody C. Carter, Hirsh Komarow, Deepti Radia, Animesh Pardanani, Karl Sotlar, Massimo Triggiani, Hans-Peter Horny, Michel Arock, Lawrence B. Schwartz, Dean D. Metcalfe
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?